End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report. Nguyen MD, Gorobets O, Djoua YJ, Rose-Dite-Modestine J, et al. Anticancer Res 2025;45:2535-2538.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nguyen MD, Gorobets O, Djoua YJ, Rose-Dite-Modestine J, et al. End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report. Anticancer Res 2025;45:2535-2538.
PMID: 40425347